Total planned funding: $340,584,602
Clear active filters
Chemonics International
HTXD: Treatment: ARV Drugs
2010
2011
2012
2013
2014
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Tanzania | $94,363,636 |
| Nigeria | $84,738,706 |
| Zambia | $58,506,547 |
| Mozambique | $24,187,059 |
| Zimbabwe | $21,411,062 |
| Haiti | $14,810,509 |
| Rwanda | $14,481,300 |
| Uganda | $13,548,375 |
| Democratic Republic of the Congo | $11,556,778 |
| Eswatini | $1,306,218 |
| Burundi | $715,195 |
| Namibia | $461,404 |
| South Sudan | $214,638 |
| Ukraine | $132,881 |
| Botswana | $100,118 |
| Cameroon | $50,176 |
| Lesotho | $0 |
| Malawi | $0 |
| Ethiopia | $0 |
| Vietnam | $0 |
| Kenya | $0 |
| South Africa | $0 |
| Côte d'Ivoire | $0 |
Organizational Types
| Private Contractor | $340,584,602 |
Program Areas
| Treatment | $340,584,602 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $340,584,602 |